Samuel Gershon, M.D.

Title: Professor and Vice Chair for Academic Affairs, Department of Psychiatry & Behavioral Sciences
Phone: 305-243-6400
Email: SGershon@med.miami.edu
Education:


1950             M.D.
                    University of Sydney, Faculty of Medicine, Sydney, Australia

1951-1952     Rotating Internship
                    Royal Prince Alfred Hospital, University of Sydney,  
                    Faculty of Medicine, Sydney, Australia

1952             Resident, Psychiatry
                    Mental Hospital and Receiving Hospital, Ballarat, Victoria, Australia

1953             Resident, Psychiatry                  
                    Psychiatric Receiving Hospital, Royal Park, Melbourne, Australia

1954             Resident, Child Psychiatry
                    Travancore Child Psychiatric Clinic, Melbourne, Australia

1954-1956     Deputy Psychiatrist, Supt.                  
                    Sunbury Mental Hospital, Sunbury, Victoria, Australia

1956             Degree in Psychiatry                  
                    University of Melbourne, DPM, Melbourne, Australia

1973             MRCP
                    Member Royal College of Psychiatrists, London, UK

1982             FRCP 
                    Fellow Royal College of Psychiatrists, London, UK

Clinical Interests:


•    Bipolar disorders
•    Alzheimer's disorders

Research Interests:


•    Psychopharmacology
•    Therapeutics affective disorders

Selected Publications:


Refereed Articles:

Himmelhoch J, Levine J., Gershon S.  Historical overview of  the relationship between anxiety disorders and affective disorders. Depress Anxiety 2001;14: 53-66.

Levine J, Chengappa KRN, Gershon S, Drevets W.  Differentiating primary pathophysiologic from secondary adaptational processes. Depress Anxiety 2001;14:105-11.

Levine J, Chengappa KNR, Brar JS, Gershon S, Kupfer D.  Illness characteristics and their association with prescription patterns for bipolar I disorder.  Bipolar Disorders 2001;3:41-49.

Pettegrew JW, Panchalingam K, McClure, Gershon S, Muenz LR, Levine J.  Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids.  Bipolar Disorders 2001;3:189-201.

Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, Gershon S, Clark D. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial. Addict Behav 2001;26:735-739.

Chengappa KN, Gershon S, Levine J.  The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.  Bipolar Disorders 2001;3:215-232.

Angrist B, Rotrosen J, Gershon S.  Commentary on: “Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.”  Psychopharmacology 2001;158:219- 221.

Levine J, Cole DP, Chengappa NR, Gershon S.  Anxiety disorders and major depression, together or apart.  Depress Anxiety 2001;14:94-104.

Pettegrew JW, Levine J, Gershon S, Stanley JA, Servan-Schreiber D, Panchalingam K, McClure, RJ.  P-MRS study of Acetyl-L-Carnitine Treatment in Geriatric Depression: Preliminary Results.  Bipolar Disorders 2002;4: 61-66.

Chengappa KN, Baker RW, Shao L, Yatham LN, Tohen M, Gershon S, Kupfer DJ. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania.  Bipolar Disorders 2003;5(1):1-5.

Soares JC, Gershon SHandbook of Medical Psychiatry.  Marcel Dekker, Inc. New York, NY. 2003.

Levine J, Panchalingam K, McClure RJ, Gershon S, Pettegrew JW.  Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study.  Neurochem Res 2003;28(5):687-90.

Buriakovsky I, Cohen H, Gershon S, Kaplan Z, Levine J, McClure R, Pettegrew J. Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats. International Journal of Neuropsychopharmacology 2005;8: 65-74.

Daversa C, Gershon S. The Lithium Story: A journey from obscurity to popular use in North American. Lithium in Neuropsychiatry: The Comprehensive Guide. Taylor & Francis Book Ltd., London, UK.

Chengappa KN, Kupfer D, Parepally H, John V, Basu R, Buttenfield J, Schlicht  P, Houck P, Brar J, Gershon S. A placebo-controlled, random assignment, parallel group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. Bipolar Disorders. 2007;9:609-617.

Books:

Rosenberg DR, Holttum JR, Gershon S. Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. New York, NY: Brunner/Mazel, Inc.; 1994.

Richards S, Musser W, Gershon S. Maintenance Pharmacotherapy for Neuropsychiatric Disorders. New York, NY: Brunner/Mazel, Inc.; 1998.

Rosenberg DR, Holttum J, Ryan N, Gershon S. Pocket Guide for the Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders.  New York, NY: Brunner/Mazel, Inc.;1997

Soares JC, Gershon S. Basic Mechanisms and Therapeutic Implications of Bipolar Disorders. New York, NY: Marcel Dekker, Inc.;1999.

Rosenberg DR, Davanzo PA, Gershon S. Pharmacotherapy for Child and Adolescent Psychiatric Disorders. New York, NY: Marcel Dekker, Inc.;2002.